7381 - 7390 of 9145 Results
Title
Year
-
OPENTitle: Chemical proteomics reveals human liver fatty acid binding protein as a predominant and selective target of triphenyl phosphateJournal Name: Environmental Science: Processes & ImpactsPublisher: Royal Society of Chemistry (RSC)Vol: 27Issue #: 9Start Page: 2865End Page: 2874Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d5em00327jBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2025/em/d5em00327jCitation Count: 1
- Enteric GFAP expression and phosphorylation in Parkinson's disease2014RESTRICTEDTitle: Enteric GFAP expression and phosphorylation in Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 130Issue #: 6Start Page: 805End Page: 815Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.12742Citation Count: 190
-
OPENTitle: Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synucleinJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 683End Page: 698Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261431108Best OA location URL: https://doi.org/10.1177/1877718x261431108Citation Count: 0
- An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks2024RESTRICTEDTitle: An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural NetworksJournal Name: Digital Signal ProcessingPublisher: Elsevier BVVol: 147Issue #:Start Page: 104407End Page: 104407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.dsp.2024.104407Citation Count: 25
-
OPENTitle: Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 45End Page: 45Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00045/pdfCitation Count: 56
-
OPENTitle: First-in-human PET neuroimaging of [18F]OXD-2314Journal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 53Issue #: 1Start Page: 410End Page: 415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1007/s00259-025-07413-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-025-07413-w.pdfCitation Count: 4
- Association of Sporadic and Genetic Parkinson’s Disease with Cancer: Insights from the PPMI Cohort2025OPENTitle: Association of Sporadic and Genetic Parkinson’s Disease with Cancer: Insights from the PPMI CohortJournal Name: GenesPublisher: MDPI AGVol: 16Issue #: 11Start Page: 1302End Page: 1302Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes16111302Best OA location URL: https://www.mdpi.com/2073-4425/16/11/1302/pdf?version=1761968839Citation Count: 0
-
OPENTitle: Inhibition or genetic reduction of ASAH1 /acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson’s patientsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 24Start Page: 2075End Page: 2087Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddaf166Best OA location URL: https://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddaf166/65278149/ddaf166.pdfCitation Count: 1
-
OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 4
- Post hoc analysis of the Exenatide‐ PD trial—Factors that predict response2018RESTRICTEDTitle: Post hoc analysis of the Exenatide‐ PD trial—Factors that predict responseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 410End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14096Citation Count: 77